SCRI Tennessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.
SCRI Tennessee Oncology Nashville has participated in 9 clinical trials.
Therapeutic areas: Multiple Myeloma, Melanoma, Melanoma Stage III.
Sponsors: Takeda, Nektar Therapeutics, Arcus Biosciences, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI Tennessee Oncology Nashville has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI Tennessee Oncology Nashville has 9 clinical trials on record. Their work covers Multiple Myeloma, Melanoma, Melanoma Stage III.
SCRI Tennessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.